[Cronkhite-Canada syndrome: an acquired, potentially reversible polyposis].
Cronkhite-Canada syndrome is an infrequent, nonadenomatous, acquired polyposis that is associated with ectodermic alterations. The etiopathogenesis and optimal therapeutic management are unknown. We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. The polypoid lesions of Cronkhite-Canada syndrome can be reversed with medical treatment. Consequently, the natural history of the disease can be modified and its prognosis improved.
Marín Serrano
Eva
E
Servicio de Aparato Digestivo, Hospital Universitario Puerta del Mar, Cádiz, España.
Guillén Mariscal
Pablo
P
Pérez-Requena
José
J
Rendón Unceta
Paloma
P
D006801:Humans; D044483:Intestinal Polyposis / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction